Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!
Authors Vetter-Kauczok CS, Ströbel P, Bröcker EB, Becker JC
Published 8 February 2008 Volume 2008:4(1) Pages 263—266
Claudia S Vetter-Kauczok1, Philipp Ströbel2, Eva B Bröcker1, Jürgen C Becker1
1Department of Dermatology, Julius-Maximilians-University Wuerzburg, Wuerzburg, Germany; 2Department of Pathology, Ruprecht-Karls-University Mannheim, Mannheim, Germany
Abstract: Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor which usually occurs in infants. Clinically it appears as ill-defined red to purple indurated plaque. KHE is commonly associated with Kasabach-Merritt syndrome (KMS) and lymphangiomatosis. Microscopically, the tumor is composed of infiltrating lobulated nodules with slitlike or crescentic vessels which are poorly canalized and lined by spindle shaped endothelial cells. We report a 36-year old female who developed a reddish tumor on the chest. Histological examination revealed a KHE, which was clinically not associated with thrombocytopenia or bleeding complications, but lymphangiomatosis at the right submandibular region. The association of KHE in a female adult with lymphangioma rather than KMS in this case supports the hypothesis that such an association may represent a benign subform of this disease in an adult and excision seems to be curative.
Keywords: Kasabach-Merritt-Syndrome, Kaposiform hemangioendothelioma, lymphangiomatosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]